English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduFirst, diabetes drugs like Ozempic and Wegovy showed promise in weight loss and have been marketed and widely used for weight loss. Now these medications are showing promise as a possible treatment for multiple sclerosis. A study, “Exploring the association…
Tag: weight loss drugs
WEGOVY APPROVED FOR HEART RISK: U-Mich cardiology, obesity medicine experts available for interview
On March 8, the U.S. Food and Drug Administration approved a new indication for the use of semaglutide (brand Wegovy) to “reduce the risk of cardiovascular death, heart attack and stroke in adults with cardiovascular disease and either obesity or…
Weight loss and diabetes management drug linked to increased residual gastric content before anesthesia
Safety concerns for patients undergoing anesthesia who use glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which are medications approved for diabetes and weight management, were revealed in a UTHealth Houston study published today in JAMA Surgery.
Obesity drugs and mental health: UTSW expert says GLP-1s may exacerbate problems for some patients
New weight-loss drugs have helped people with their diabetes, obesity, even high blood pressure. But how they affect our mental health is a much more complicated issue, says Dr. Carrie McAdams, a psychiatrist and eating disorders expert at UT Southwestern…
Should heart patients consider taking weight loss medications?
Over the last year, prescriptions for medications that can accelerate weight loss in people with diabetes, or without it, have skyrocketed. But how can these weight loss medications affect the heart? A preventive cardiologist shares how this shifting landscape might affect cardiovascular care and how he advises his patients.